https://wikimd.org/index.php?action=history&feed=atom&title=HIV_Vaccine_Trials_NetworkHIV Vaccine Trials Network - Revision history2026-04-25T21:23:37ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=HIV_Vaccine_Trials_Network&diff=5816908&oldid=prevPrab: CSV import2024-05-24T17:21:05Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Hvtn_logo.jpg|thumb|Hvtn logo]] '''HIV Vaccine Trials Network'''<br />
<br />
The '''HIV Vaccine Trials Network''' ('''HVTN''') is an international collaboration of scientists and institutions dedicated to developing and testing preventive [[HIV]] vaccines. The network is funded by the [[National Institute of Allergy and Infectious Diseases]] (NIAID), which is part of the [[National Institutes of Health]] (NIH) in the [[United States]].<br />
<br />
==History==<br />
The HVTN was established in 1999 to address the global challenge of [[HIV/AIDS]]. The network's primary goal is to conduct clinical trials to evaluate the safety and efficacy of candidate HIV vaccines. The HVTN builds on the work of earlier HIV vaccine research efforts and collaborates with other organizations involved in HIV prevention research.<br />
<br />
==Structure==<br />
The HVTN is headquartered at the [[Fred Hutchinson Cancer Research Center]] in [[Seattle]], [[Washington (state)|Washington]]. It includes a network of clinical trial sites located in the [[United States]], [[South America]], [[Africa]], and [[Asia]]. These sites are responsible for recruiting participants, conducting trials, and collecting data.<br />
<br />
==Research and Trials==<br />
The HVTN conducts a range of clinical trials, from early-phase studies to large-scale efficacy trials. These trials are designed to test various aspects of HIV vaccines, including their ability to induce immune responses and their effectiveness in preventing HIV infection. The network collaborates with other research organizations, including the [[International AIDS Vaccine Initiative]] (IAVI) and the [[Bill & Melinda Gates Foundation]].<br />
<br />
==Key Achievements==<br />
The HVTN has made significant contributions to the field of HIV vaccine research. Some of its key achievements include:<br />
* Conducting the first large-scale efficacy trial of an HIV vaccine in the United States.<br />
* Developing innovative trial designs and methodologies to improve the evaluation of HIV vaccines.<br />
* Establishing a robust infrastructure for conducting HIV vaccine trials globally.<br />
<br />
==Challenges and Future Directions==<br />
Despite significant progress, developing an effective HIV vaccine remains a challenging task. The HVTN continues to explore new vaccine candidates and strategies, including the use of novel vaccine platforms and combination approaches. The network is also focused on understanding the immune responses required for protection against HIV and identifying correlates of protection.<br />
<br />
==See Also==<br />
* [[HIV/AIDS research]]<br />
* [[Vaccine development]]<br />
* [[Clinical trial]]<br />
* [[National Institute of Allergy and Infectious Diseases]]<br />
* [[Fred Hutchinson Cancer Research Center]]<br />
<br />
==References==<br />
{{Reflist}}<br />
<br />
==External Links==<br />
{{Fred Hutchinson Cancer Research Center}}<br />
<br />
[[Category:HIV/AIDS research]]<br />
[[Category:Clinical trials]]<br />
[[Category:Vaccines]]<br />
[[Category:Medical research organizations]]<br />
[[Category:National Institutes of Health]]<br />
<br />
{{healthcare-stub}}</div>Prab